The board of directors of New Ray Medicine International Holding Limited announced that Mr. Dai Haidong has tendered his resignation as an executive Director and the Chief Executive Officer of the company with effect from November 5, 2015 due to health reasons. Accordingly, Mr. Dai also ceased to be a member of the corporate governance committee of the Board on the same date. Following Mr. Dai's resignation, Ms. Yang Fang, an executive Director, will be appointed as the Chief Executive Officer of the Company with effect from November 5, 2015.

Ms. Yang Fang has been an executive Director since October 2013. Ms. Yang joined the Group in 2005. Prior to joining the Group, Ms. Yang was a pharmacist of Zhejiang Province Prison's Hospital from 1995 to 2004 and a quality control officer of Hainan Rich Medicine Co.

Ltd. from 2004 to 2007. She has over 16 years of experience in the pharmaceutical industry. She completed an on-line post-secondary course in pharmacy at Institute of Distance Education of Zhejiang University in 2008.